AB-CHFUPYCA

AB-CHFUPYCA is a synthetic cannabinoid that has immense potential for research. This comprehensive guide will provide you with important information about AB – CHFUPYCA including its development and chemical properties. We’ll also cover the effects, uses, and dosage.

Development and Background

AB-CHFUPYCA, a synthetic cannabinoid, is part of the AB Series. It was also called the FUBINACA Series. While it is not known who developed AB-CHFUPYCA, its unique pharmacological characteristics and structural similarity to other synthetic cannabinoids such as AB-FUBINACA or AB-CHMINACA have attracted considerable interest among researchers.

CAS Number and Chemical name

The CAS number for ABCHFUPYCA (Chemical Abstracts Service), 1187968-94-6 is used as a unique identifier in scientific databases. The IUPAC (International Union of Pure and Applied Chemistry) name for AB-CHFUPYCA is N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide. This name provides researchers with a standard reference and describes the chemical structure of the compound.

Molecular Formula

The molecular formula of AB-CHFUPYCA is C23H30FN3O2, which means that it contains 23 Carbon atoms. It also contains 30 Hydrogen atoms. Its molecular mass is 395.50 grams/mol.

Compound Color and Shape

AB-CHFUPYCA is typically a powdery white or off-white color. Its crystalline structure makes it easy to dissolve in different solvents and is therefore ideal for research. Store AB-CHFUPYCA away from heat, direct sunlight, and in a dry, cool place to maintain its integrity.

Uses and effects of AB-CHFUPYCA

AB-CHFUPYCA is not approved for human consumption, nor medical use. However, it has been used in scientific research as a powerful agonist of the CB1 cannabinoid receptors. These receptors are essential in many physiological processes such as the regulation of pain, immune system function and mood regulation. Researchers are studying AB-CHFUPYCA in order to better understand both the endocannabinoid and synthetic cannabinoids.

AB-CHFUPYCA has a high affinity and selectivity towards the CB1 (brain) receptor. The compound mimics the effects of cannabinoids such as THC. These effects can include euphoria and relaxation, as well as altered perceptions and an increased appetite. Due to its potency, AB – CHFUPYCA may also have more intense effects, and a greater risk of side effects.

Dosage and precautions

AB-CHFUPYCA, a research chemical that has not been approved by the FDA for human consumption is to be handled with extreme caution. Researchers who work with AB-CHFUPYCA must adhere to strict safety protocol, including wearing personal protective equipment.

The dosage of AB – CHFUPY is the same for in vitro and in vivo studies.

YCA must be determined carefully based on study objectives and conditions. When designing experiments, researchers must also consider the compound’s potency as well as its potential for adverse effects.

AB-CHFUPYCA has significant research potential. Researchers who are interested in the endocannabinoid and synthetic cannabinoids’ potential therapeutic applications will find its unique chemical structure, pharmacological profiles, and ease of use ideal. Researchers can unlock the mysteries surrounding AB-CHFUPYCA, and other synthetic cannabinoids by adhering to strict safety protocols and following relevant legal guidelines.